DGX Quest Diagnostics: Market Capitalization to Book Value Ratio

Official company branding of Quest Corp (DGX)

Quest Diagnostics demonstrates resilience to economic fluctuations due to stable demand for diagnostics. The current ratio of the company's value to its book capitalization on the GURU.Markets consolidated chart shows that the 3.48 indicator expresses the state of the metric. Jim Davis's strategy relies on the acquisition of local laboratories, while the implementation of ESG standards optimizes medical waste processing.

Quest Corp (DGX): Capitalization to Book Value Ratio from 07/04/2022 to 10/27/2026
Core merchandise of Quest Diagnostics Inc.

For Quest Diagnostics (DGX), stable demand for laboratory testing and insurance reimbursements form an asset base that the market evaluates through the lens of capital management efficiency. By analyzing the company's market-to-book ratio, an investor determines the market price premium over the value of net assets, where an increasing value signals confidence in future earnings but elevates the risk of a correction.

Main competitors

A (Agilent Technologies) - Market Value to Book Value Ratio|illumina.com (ILMN) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio EXAS (Exact Sciences Corporation)|Market-to-Book Ratio Revvity Inc|Market Capitalization to Book Value Ratio Bio-Rad Laboratories Inc BIO|Capitalization to Book Value Ratio Anbio Corp (NNNN)|Market Capitalization to Book Value Ratio SHC (Sotera Health Company)|quidel.com - Market Capitalization to Book Value Ratio|OPKO Health (OPK) - Market Value to Book Value Ratio|CDNA - Capitalization to Book Value Ratio|MRVI: Market Capitalization to Book Value Ratio|FLGT (Fulgent) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Standard BioTools Inc.|Market Value to Book Value Ratio cytekbio.com (CTKB)|OraSure - Market Cap to Net Assets Ratio|Market-to-Book Ratio XGN (exagen.com)|Market Value to Book Value Ratio MDXH|Market Capitalization to Book Value Lucid Diagnostics, Inc LUCD|Market Capitalization to Book Value Ratio PRE (Prenetics Global Ltd)|IMDX: Market Capitalization to Book Value|trinitybiotech.com - Market Value to Book Value Ratio|PRPH (ProPhase Labs Inc) - Market Capitalization to Book Value|Ainos Corp - Market Value to Book Value Ratio|Market Value to Equity Ratio CoDx (CODX)|Market Cap to Net Assets Ratio HSCS|Market Capitalization to Book Value Ratio biomerica.com (BMRA)|CDIO: Market Capitalization to Book Value Ratio|Virax Biolabs Group Limited - Market-to-Book Ratio|Market Value to Book Value Ratio BJDX (Bluejay)|Aspira Women's Health Inc (AWH) - Market Capitalization to Book Value|AXDX - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple CENTOGENE|ENZ - Market Cap to Net Assets Ratio|Market Value to Book Value Fresh2|Market Capitalization to Book Value Ratio Genetic Technologies GENE|Capitalization to Book Value Ratio 23andMe Inc (ME)|Market Capitalization to Book Value Ratio PMD